1,090,056 Shares in Omada Health, Inc. $OMDA Acquired by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P acquired a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA) during the second quarter, Holdings Channel.com reports. The fund acquired 1,090,056 shares of the company’s stock, valued at approximately $19,948,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. XTX Topco Ltd acquired a new stake in shares of Omada Health during the 2nd quarter valued at $414,000. Eisler Capital Management Ltd. purchased a new stake in shares of Omada Health during the second quarter worth $545,000. Geode Capital Management LLC acquired a new stake in Omada Health during the second quarter valued at $637,000. Teacher Retirement System of Texas purchased a new position in Omada Health in the second quarter valued at about $640,000. Finally, Franklin Resources Inc. acquired a new position in Omada Health in the 2nd quarter worth about $2,695,000.

Omada Health Price Performance

Shares of Omada Health stock opened at $18.73 on Monday. The stock’s 50 day moving average is $22.57. Omada Health, Inc. has a 12-month low of $14.14 and a 12-month high of $28.40.

Wall Street Analyst Weigh In

OMDA has been the subject of several research reports. Needham & Company LLC lifted their price target on Omada Health from $26.00 to $28.00 and gave the company a “buy” rating in a report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a research report on Wednesday, October 8th. Canaccord Genuity Group boosted their target price on shares of Omada Health from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Friday, August 8th. Evercore ISI increased their price target on shares of Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. Finally, Robert W. Baird began coverage on shares of Omada Health in a research note on Friday, September 5th. They issued a “neutral” rating and a $24.00 price objective for the company. Eight equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $26.33.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.